Diesel exhaust (DE) as the major source of vehicle-emitted particle matter in ambient air impairs lung function. The objectives were to assess the contribution of local (eg, the fraction of exhaled nitric oxide [FeNO] and serum Club cell secretory protein [CC16]) and systemic (eg, serum C-reaction protein [CRP] and interleukin-6 [IL-6]) inflammation to DEinduced lung function impairment using a unique cohort of diesel engine testers (DETs, n ¼ 137) and non-DETs (n ¼ 127), made up of current and noncurrent smokers. Urinary metabolites, FeNO, serum markers, and spirometry were assessed. A 19% reduction in CC16 and a 94% increase in CRP were identified in DETs compared with non-DETs (all p values <10 À4 ), which were further corroborated by showing a dose-response relationship with internal dose for DE exposure (all p values <.04) and a time-course relationship with DE exposure history (all p values <.005). Mediation analysis showed that 43% of the difference in FEV1 between DETs and non-DETs can be explained by circulating CC16 and CRP (permuted p < .001). An inverse dose-dependent relationship between FeNO and internal dose for cigarette smoke was identified (p ¼ .0003). A range of 95% lower bounds of benchmark dose of 1.0261-1.4513 lg phenanthrols/g creatinine in urine as an internal dose was recommended for regulatory risk assessment. Local and systemic inflammation may be key processes that contribute to the subsequent development of obstructive lung disease in DE-exposed populations.
Research and Development and National Center for Environmental Assessment (Washington D.C.), 2002). Chronic exposure to DE causes several adverse respiratory health events, including pulmonary inflammation, increased susceptibility to respiratory infection, and exacerbation of asthma and chronic obstructive pulmonary disease (COPD) in vulnerable populations such as children and seniors (Breton et al., 2012; Ristovski et al., 2012; Steiner et al., 2016 Several circulating proteins have been studied in relation to lung function in general populations. Club (formerly Clara) cell secretory protein (CC16) is a homodimeric pneumoprotein that is mainly produced by club cells in the distal airways and can be measured in circulation (Broeckaert and Bernard, 2000) . Growing evidence indicates that CC16 has anti-inflammatory and antioxidant properties in the lung (Broeckaert and Bernard, 2000) and may protect against age-related lung function decline in the general population and patients with COPD (Guerra et al., 2015; Park et al., 2013; Vestbo et al., 2011) . Long-term cigarette smoking results in decreased numbers of club cells and levels of serum CC16 (Shijubo et al., 1997) . C-reactive protein (CRP) is an acute-phase reactant, produced by the liver in response to interleukin-6 (IL-6), and is a sensitive marker of systemic inflammation (Pepys and Hirschfield, 2003) . Greater blood CRP level has consistently been found to be associated with a more rapid subsequent decline of FEV1 in young adults before the onset of age-related lung function decline (Olafsdottir et al., 2013; Rasmussen et al., 2009) . The fraction of exhaled nitric oxide (FeNO) has been employed as a noninvasive index of allergic and eosinophilic airway inflammation. Inducible nitric oxide synthase (iNOS) plays an important role in determining nitrosative stress in the lungs of asthmatic patients, as it produces large amounts of nitric oxide (NO) in response to environmental stimuli (Ricciardolo et al., 2004) .
The effect of DE exposure on local (eg, FeNO and CC16) and systemic inflammatory (eg, CRP and IL-6) markers has only been studied in humans under an acute controlled exposure setting or with exposure to residential traffic-related air pollution. In acute controlled exposure studies, a limited number of adult subjects were exposed to 300 lg/m 3 DE for 1 or 3 h and increased levels of FeNO and IL-6 in sputum and reduced level of CC16 in bronchoalveolar lavage were detected up to 24 h postexposure (Barath et al., 2013; Biagioni et al., 2016; Nordenhall et al., 2001) . In epidemiological studies, residential trafficrelated pollution exposure has usually been quantified using distance to traffic, intensity of roads within certain distance, and PM and identified an overall positive correlation between exposure index and circulating CRP and IL-6 levels (Delfino et al., 2009; Hennig et al., 2014; Hoffmann et al., 2009; Lanki et al., 2015; Rioux et al., 2010; Zhao et al., 2013) . Moreover, residential traffic-related pollution exposure was also associated with greater level of FeNO in asthmatic children and adopting clean fuels and technologies on school buses was associated with reduction in FeNO in asthmatic children and greater growth in lung function (Adar et al., 2015; Eckel et al., 2011) . However, general and occupational populations were usually exposed to a complex mixture of air pollutants that may confound the association between DE exposure and the health outcomes. For example, in addition to DE, underground uranium miners were also exposed to silica dust, radon gas, and typically cigarette smoke (Leng et al., 2016) . Furthermore, the estimation of DE exposure using proximate approaches such as distance to traffic or intensity of roads within a certain distance only provide crude estimations of overall air pollution that each individual may be exposed to. Recently, we characterized a unique occupational cohort of diesel engine testers (DETs) who exam the performance of the newly assembled diesel-fueled vehicle engines for quality assurance in China (Figure 1) (Zhang et al., 2015) . Environmental monitoring at the workplace suggested that DETs were exposed to high levels of PM2.5 (282.3 lg/m 3 ) and elemental carbon (135.2 lg/m 3 ) (Zhang et al., 2015) . Mechanistic biomarkers related to cancer risk (eg, DNA and chromosome damage in white blood cells), oxidative stress (eg, lipid peroxidation products in urine), and systemic inflammation (eg, total lymphocyte count and major lymphocyte subsets) were all increased in DETs compared with non-DETs (Bin et al., 2016; Duan et al., 2016; Lan et al., 2015; Zhang et al., 2015 Zhang et al., , 2016 . Most recently, using the same cohort, DETs were shown to have significant changes in spirometry measurements indicative of airway obstruction and small airway function impairment (Zhang et al., 2017) . The current study assessed the effect of chronic exposure to DE and cigarette smoke on local (ie, FeNO, CC16, and surfactant protein A [SPA] ) and systemic inflammation (ie, CRP and IL-6) markers using the well-characterized DET cohort comprises 137 DETs and 127 non-DETs. Individual exposure to DE and cigarette Figure 1 . A hypothetical relationship among chronic diesel exhaust (DE) exposure, local and systemic inflammatory markers, and lung function impairment tested in a male diesel engine tester (DET) cohort in China. Pictures depict the working environment of DETs. Our findings provide a strong evidence that local and systemic inflammation are key processes that may contribute to the subsequent development of obstructive lung disease in DE exposed populations.
smoke was assessed using a panel of urinary metabolites of polycyclic aromatic hydrocarbons (PAHs). How these inflammatory markers mediated the association between DE exposure and lung function was assessed as well.
MATERIALS AND METHODS
Study subjects. Detailed description of the DET cohort and the working environment has been previously described (Zhang et al., 2015) . There were a total of 20 diesel engine dynamometers in the workshop, each installed within a semi-enclosed structure (Figure 1 ). The engines after assembly without an after-treatment system were directly tested according to the cycles recommended by US EPA. Approximately 5-15 dynamometers were in use at any time. The engine exhaust was expelled outside of the workshop through emission pipes. However, DE that leaked through the joints of the pipes was diffused inside the workshop. Passive ventilation occurred through the windows on the roof (Figure 1 ). Cigarette smoking was strictly prohibited inside the diesel engine testing facility. Thus, it is highly unlikely that any photo-and atmospheric chemistry could occur inside the workshop. The DE exposed group included 137 male workers from a diesel engine manufacturing plant who had been testing heavy-duty diesel engines for at least six months prior to the enrollment into this study. The non-DETs group consisted of 127 male workers from a water utility authority in the same city. Environmental monitoring identified high ambient air pollution of particulate matter in the diesel engine testing workplace compared with the water utility authority (eg, PM2 Urinary metabolites. One-hydroxynaphthalene (1-OHNa), 2-hydroxynaphthalene (2-OHNa), 2-hydroxyfluorene (2-OHFlu), 2-hydroxyphenanthrene (2-OHPh), 9-hydroxyphenanthrene (9-OHPh), and 1-hydroxypyrene (1-OHP) were quantified in urine samples collected at the end of shift after at least four consecutive working days (Huang et al., 2010) .
Blood markers of inflammation. Serum IL-6 was measured using a BD Cytometric method (BD Biosciences). Serum CRP was measured using an immunoturbidimetric assay (DiaSys, Germany). Serum CC16 (Biovendor) and SPA (R&D) were measured by sandwich ELISA according to the manufacturer's instructions. DE and non-DETs were randomized in the queue and technicians were unaware of the exposure status.
Spirometry. Spirometry data were collected by certified pulmonary function technicians using a portable calibrated vitalograph spirometer (CHESTAC-8800, Japan) in accordance with the American Thoracic Society and European Respiratory Society standards (Miller et al., 2005) . The spirometer was calibrated at least twice a day at the beginning and end of the examination according to the manufacturer's guidelines. Mediation analysis was conducted to evaluate whether local and systemic inflammation could explain the differences in lung function between the two exposure groups with the significance level estimated using a permutation test (Baron and Kenny, 1986) . The delta change of the beta coefficients for DE exposure status between GLMs for FEV1 with and without adjustment for serum CC16 and CRP reflected the magnitude of the DE effect explained by these two serum biomarkers. All statistical analyses were conducted in SAS 9.4.
Benchmark dose estimation. The U.S. Environmental Protection Agency Benchmark Dose Software Version 2.6 was used to calculate benchmark dose (BMD) and its lower bound (BMDL) of the one-sided 95% confidence interval associated with a benchmark response (BMR). A BMR for 10% excess risk above the adverse response rate seen in the control group was chosen (Wang et al., 2013) . Four endpoints related to lung function impairment including serum CRP, CC16, FEV1, and FEV1/FVC were considered. Serum CRP concentration >1 mg/L was associated with moderate to high risk for cardiovascular disease (Pearson et al., 2003) , thus was selected as the cutpoint to define an abnormal change. Lower quartiles of serum CC16, FEV1, and FEV1/FVC in nonDETs were selected as the cutpoints for defining any abnormal change because no cutpoint of CC16 for a certain health outcome has ever been established and none of the study subjects had severely compromised lung function (ie, FEV1/FVC < 0.7). Among all four PAH metabolites measured in urine, OHPh as an internal exposure biomarker most specific for DE exposure was used as the exposure dosimetry in the BMD calculation. Dieselexposed workers were evenly divided into three groups based on urinary OHPh levels (ie, low 0.28-2.14, medium 2.14-3.78, and high 3.78-56.88 lg/g creatinine). Because of the skewed distribution of urinary OHPh within each exposure group (ie, non-DETs, low, medium, and high), median and geometric mean of urinary OHPh were used to calculate BMD and BMDL. No difference was identified for BMD and BMDL estimated based on median or geometric mean, therefore only results based on median are presented. Unlike many in vitro cellular and in vivo animal studies where the exposure level in the control group is zero, the level of urinary OHPh in this study's control group was above zero. The median OHPh level in the control group (0.64 mg/g creatinine) was subtracted from the median of each exposure group prior to BMD modeling to minimize the potential bias due to data extrapolation beyond the observed dose range. Thus, the reported BMD and BMDL of urinary OHPh for each outcome were the values calculated by BMDS with the smallest Akaike information criterion value plus the median OHPh level in the control group (0.64 mg/g creatinine).
RESULTS
DETs had significantly shorter duration of smoking in current smokers (9 vs 12 years, p ¼ .0005) and greater prevalence of overweight (43.1% vs 30.7%, p ¼ .037) compared with non-DETs (Table 1) . Socioeconomic status was comparable between the two study groups as >80% study subjects within each group completed high school or higher education. DE exposure history in DETs ranged from 0.6 to 36.8 years with a median of 8.5 years. The levels of urinary metabolites (ie, 2-OHFlu, 1-OHP, 1-& 2-OHNa, and 2-& 9-OHPh) in DETs were 2.5-to 4.4-fold greater than that seen in non-DETs with OHPh having the largest difference between the two groups (Table 1) .
FeNO, Blood Biomarkers, and Spirometry Between Non-DETs and DETs Among the four blood biomarkers related to lung injury and systemic inflammation, significant differences for CC16 and CRP between the two study groups were identified with DETs having lower CC16 but higher CRP compared with non-DETs (ps < 10 À4 , Table 2 ). In addition, DETs had significantly lower FEV1 (p ¼ .0062) and FEV1/FVC ratio (p ¼ .0003) compared with nonDETs, suggesting a restrictive pattern of lung function impairment caused by chronic DE exposure (Table 2) . Significantly elevated SPA was detected in DETs compared with non-DETs (p ¼ .042, Table 2 ). Interestingly, no difference of FeNO was identified between non-DE and DETs (Table 2) .
Variance Specific for Exposure to DE or Cigarette Smoke
Among four types of urinary metabolites measured in this study, 2-& 9-OHPh was exclusively correlated with DE exposure status (Supplementary Table S1 ). One-& 2-OHNa, 1-OHP, and 2-OHFlu were correlated with both DE exposure and cigarette smoke with 1-& 2-OHNa predominantly correlated with exposure to cigarette smoke and 1-OHP and 2-OHFlu predominantly correlated with DE exposure (Supplementary Table S1 ). Principal component analysis was conducted based on urinary Note: Current smokers were defined as individuals who had smoked more than 100 cigarettes in their lifetime and continued to smoke during the period of interview or if quit, quit within 1 month prior to interview. Current alcohol users were defined as individuals who consumed alcohol containing products (eg, wine, beer, and hard liquor) more than twice a week in the last 6 months. FeNO and serum biomarkers were summarized as geometric mean and p5-p95.
Spirometry was summarized as mean and p5-p95. For FeNO and serum biomarkers as the outcome, natural log-transformed data were used as the outcome in the GLM that included age, overweight, cigarettes per day, and smoking duration for covariate adjustment. Serum IL-6 was additionally adjusted in the model for CRP. For spirometry as the outcome, age, height, BMI, cigarette per day, and smoking duration were adjusted in GLM. Cigarettes per day and smoking duration were coded as zero for never smokers.
metabolites and generated four PCs. The first and second PCs explained 76% and 18% of the total variance, respectively, with 2-OHFlu, 1-OHP, and 2-& 9-OHPh mainly contributing to PC1, whereas 1-& 2-OHNa mainly contributed to PC2 (Supplementary Table S2 ). Spearman correlation analysis suggested that PC1 is highly correlated with exposure to DE (r > .64), whereas PC2 is highly correlated with cigarettes per day and current smoking (rs > .63) (Supplementary Table S3 ). Thus, PC1 and PC2 can be used as an index of exposure for DE and cigarette smoke, respectively.
Differential Effects of Environmental Exposures
In order to assess the dose-response relationship between exposure index specific for DE or cigarette smoke and biomarkers or lung function, tertiles (ie, 33th and 66th percentiles) of PC1 and PC2 were used to divide the entire study population into three groups with different levels of DE exposure or cigarette smoke exposure, respectively (Tables 3 and 4) . With adjustment for internal dose of cigarette smoke exposure (PC2) and additional covariates, significant associations between levels of CC16 and CRP and internal dose of DE exposure (PC1) were identified with CC16 (p ¼ .034) and CRP (p ¼ .0090) showing reduction and increase with the increasing DE exposure, respectively (Table 3) . Reduction in FEV1 was associated with increasing DE exposure as well (p ¼ .041, Table 3 ). Because 2-& 9-OHPh was exclusively associated with DE exposure, analyses were repeated using 2-& 9-OHPh instead of PC1 in the model and identified the same associations with CC16 and CRP as reported above (not shown).
With adjustment for internal dose of DE exposure (PC1) and additional covariates, significant associations between FeNO and internal dose of cigarette smoke exposure (PC2) were identified with FeNO showing reduction with increasing cigarette smoke exposure (p ¼ .0003, Table 4 ). Trends of associations between CC16 and CRP and internal dose of cigarette smoke exposure similar to that seen between CC16 and CRP and internal dose of DE exposure were observed, though not reaching statistical significance (ps > .14, Table 4 ).
Effects of DE Exposure History in DETs
Longer DE exposure history was associated with reduction in CC16 and increase in CRP in DETs with adjustment for internal dose of exposure to DE and cigarette smoke and additional covariates (ps < .005, Table 5 ). Reduction in SPA was also Tertiles for PC1 were used to divide the entire study population into three groups with different levels of DE exposure (ie, PC1 < -0.67 for low, -0.67 PC1 < 0.18 for medium, and PC1 ! 0.18 for high). FeNO and serum biomarkers were summarized as geometric mean and p5-p95. Spirometry was summarized as mean and p5-p95. For
FeNO and serum biomarkers as the outcome, natural log-transformed data were used as the outcome in the GLM with adjustment for age, overweight, and PC2. Serum IL-6 was additionally adjusted in the model for CRP. For spirometry as the outcome, age, height, BMI, and PC2 were adjusted in the GLM. Tertiles for PC2 were used to divide the entire study population into three groups with different levels of cigarette smoke exposure (ie, PC2 < -0.41 for low, -0.41 PC2 < 0.03 for medium, and PC2 ! 0.03 for high). FeNO and serum biomarkers were summarized as geometric mean and p5-p95. Spirometry was summarized as mean and p5-p95. For FeNO and serum biomarkers as the outcome, natural log-transformed data were used as the outcome in the GLM with adjustment for age, overweight, and PC1. Serum IL-6 was additionally adjusted in the model for CRP. For spirometry as the outcome, age, height, BMI, and PC1 were adjusted in the GLM.
associated with longer DE exposure history (p ¼ .013). Interestingly, reduction in FeNO was also associated with longer DE exposure history (p ¼ .044).
Mediation Effects of Circulating CC16 and CRP CC16 produced by club cells in the distal airways has antiinflammatory and antioxidant properties in the lung and may protect against obstructive lung diseases. CRP produced primarily in the liver in response to IL-6 is a sensitive biomarker for systemic inflammation, and its concentration has consistently been shown to be associated with a more rapid decline in FEV1 (Olafsdottir et al., 2013; Rasmussen et al., 2009 ). Significant positive and inverse correlations were identified between circulating CC16 and FEV1 and between circulating CRP and FEV1, respectively, in all study subjects and in each exposure group (Figure 2) . Thus, we hypothesized that the effect of DE on FEV1 loss may be mediated by CC16 and CRP levels. Mediation analyses identified that the addition of CC16 and CRP in the models dramatically reduced the magnitude of association between DE exposure and FEV1 by 43% and the association between DE exposure and FEV1 became completely insignificant (p ¼ .14). The correspondence between the vector of variables and FEV1 was permuted 1000 times and for each permutation, a delta change for the estimate of the slope associated with DE exposure between the two models with and without CC16 and CRP was calculated. After 1000 permutations, no delta change was greater than the one observed from the original data, suggesting a permuted p value <.001 (Table 6 ).
Determinants for FeNO and Blood Biomarkers
Because of the important role of FeNO, CC16, and CRP in lung diseases, we further assessed their determinants in all study subjects. GLMs were established for these three endpoints and explained a moderate proportion of variability in FeNO (10%), CC16 (15%), and CRP (19%) levels. Age was associated with greater FeNO level (p ¼ .0059). Higher intensity (p ¼ .029) and longer duration of smoking (p ¼ .044) were associated with lower FeNO level. On the contrary, cigarette smoking was not associated with CC16 and CRP levels (ps > .18). Overweight (ps < .004) and DE exposure (ps < 10
À4
) were associated with lower CC16 and higher CRP levels. The associations related to age, cigarette smoking, and overweight were also observed in DETs (not shown) (Table 7) .
BMD and BMDL Estimation BMD and BMDL were calculated for serum CC16, CRP, and FEV1/ FVC because a monotonically increasing dose-response pattern was identified between urinary OHPh and adverse event rates (Table 8) . Because there was very little difference in the model fitness across the six models, ranges of BMDLs of urinary OHPh from all the models are presented for serum CC16 (1.0261-1.4513 lg/g creatinine) and CRP (1.2082-1.598 lg/g creatinine), and FEV1/FVC (1.3448-1.8115 lg/g creatinine) in Table 9 with the bestfitted models as shown in Supplementary Figure S1 . BMDLs estimated based on serum CC16 and CRP were much lower than that based on FEV1/FVC with BMDLs estimated for CC16 as the lowest supporting serum CC16 as a more sensitive biomarker related to lung injury induced by chronic DE exposure.
DISCUSSION
This is the first study that systemically assessed the effects of chronic exposure to a high level of DE on local and systemic inflammatory markers relevant to lung function impairment using a well-characterized male DET cohort (Figure 1 ). Crosssectional comparisons identified a 19% reduction in serum CC16 and a 94% increase in serum CRP in DETs compared with nonDETs. These findings were further corroborated by showing a dose-response relationship with internal dose highly specific for DE exposure (ie, PC1 and OHPh) and a time-course relationship with DE exposure history, respectively. The increased local and systemic inflammation as reflected by decreased CC16 and increased CRP in circulation were not due to severely compromised lung function because none of the study subjects were diagnosed with COPD. Thus, we hypothesized that it was chronic DE exposure that caused damage and reduction in the number of club cells and stimulated the secretion of CRP in liver that further impaired lung function. This hypothesis was supported by results from mediation analysis that showed that 43% of the difference in FEV1 between the two exposure groups can be explained by circulating CC16 and CRP. In addition, the literature has established a temporal relationship between baseline high CRP levels and a more rapid decline of FEV1 in young male adults with an age range similar to our study population (Olafsdottir et al., 2013; Rasmussen et al., 2009) . Our study provides strong in vivo evidence that local and systemic inflammation is a key process that may contribute to the subsequent Tertiles for occupational history of DE exposure were used to divide the entire study population into three groups with different length of DE exposure history (ie, 0.6-6.3 years for short, 6.3-9.3 years for medium, and 9.3-36.8 years for long). FeNO and serum biomarkers were summarized as geometric mean and p5-p95. Spirometry was summarized as mean and p5-p95. For FeNO and serum biomarkers as the outcome, natural log-transformed data were used as the outcome in the GLM that has age, overweight, PC1, and PC2 adjusted. Serum IL-6 was additionally adjusted in the model for CRP. For spirometry as the outcome, age, height, BMI, PC1, and PC2 were adjusted in the GLM.
development of obstructive lung disease in DE exposed populations. Nitric oxide plays a key role in the physiological regulation of many airway functions, including pulmonary circulation and resistance to pathogens (Ricciardolo et al., 2004) . Increased expression of iNOS in airway epithelium and infiltrating inflammatory cells caused elevated FeNO in asthmatic airways (Ricciardolo et al., 2004) . Moreover, residential traffic-related pollution exposure has been shown to be associated with greater levels of FeNO in asthmatic children, and the adoption of clean fuels and technologies on school buses is associated with reduction in FeNO in asthmatic children and greater growth in lung function (Adar et al., 2015; Eckel et al., 2011) . In this study, chronic DE exposure assessed as DE exposure status and internal dose did not lead to a significant change of FeNO, although an inverse correlation was identified between DE exposure history and FeNO in DETs. Three DETs and one non-DET reported having allergic diseases with one DET having asthma, and the other three having allergic rhinitis. FeNO levels of these four subjects were 30, 121 (asthmatic DET), 126, and 181 ppb (non-DET), which were much higher than the average of 16.2 and 16.5 ppb in non-DE and DETs respectively, consistent with the fact that allergic airway diseases could cause elevation in FeNO. However, the effect of DE exposure on FeNO production in asthmatic workers could not be tested due to only one study subject with asthma. It is important to note that, for the first time we provided strong evidence that FeNO level was inversely associated with internal dose specific for cigarette smoking in a dose-dependent manner in a context of complex PM exposure. This result supports the findings from the literature that selfreported cigarette smoking status was associated with reduction in FeNO (Jin et al., 2011; Persson et al., 1994) . The underlying mechanisms may be through decreasing nitric oxide production by inhibiting transcription of certain NO synthases or increasing oxidative degradation of nitric oxide to reactive nitrating species (Hoyt et al., 2003; Jin et al., 2011; Ricciardolo et al., 2004) . SPA, as a pulmonary surfactant protein, is mainly synthetized and secreted by alveolar type II cells and involved in pulmonary surfactant homeostasis (Liu et al., 2003) . Patients with pulmonary alveolar proteinosis and idiopathic pulmonary fibrosis have greater SPA in circulation associated with worse prognosis (Greene et al., 2002; Kuroki et al., 1993) . DE exposure status and internal dose specific for DE exposure were associated with greater levels of SPA in serum, suggesting chronic DE exposure may either impair epithelial integrity or cause type II cell hyperplasia. However, an inverse correlation between DE exposure history and serum SPA was identified in the DETs, suggesting that a longer period of DE exposure may trigger an adaption response in maintaining surfactant implicated lung homeostasis or cause type II cell function impairment or cell loss, a hypothesis for future testing.
Although studies in humans under an acute controlled exposure setting or with exposure to residential traffic-related air Urinary OHPh, an internal exposure biomarker specific for DE exposure was used as the exposure dosimetry. Diesel-exposed workers were evenly divided into three groups based on urinary OHPh levels (ie, low 0.28-2.14, medium 2.14-3.78, high 3.78-56.88 lg/g creatinine). Median and lower and upper quartiles were presented.
b Serum CRP concentration >1 mg/l was selected as the cut point to define an abnormal change. Lower quartiles of serum CC16, FEV1, and FEV1/FVC in nondiesel workers were selected as the cut points for defining any abnormal change. 
The bestfitted model for CRP was quantal-linear with formula of
pollution have identified positive correlations between DE exposure or exposure index of traffic-related air pollution and sputum or serum IL-6 and CRP (Delfino et al., 2009; Hennig et al., 2014; Hoffmann et al., 2009; Lanki et al., 2015; Nordenhall et al., 2001; Rioux et al., 2010; Zhao et al., 2013) , our study did not identify any association between DE exposure level or duration and serum IL-6. One possible explanation might be that the use of a control population with high PM2.5 background concentrations may blunt the overall effect of DE exposure on serum IL-6 produced mainly from macrophages and monocytes (Behndig et al., 2011) . Indeed, the serum IL-6 level in the control population in this study was much higher than levels seen in populations from regions with much lower air PM2.5 pollution (Lin et al., 2014; Meyer et al., 2010) . IL-6 is the major mediator for hepatocytic secretion of most acute phase reactants. Although levels of serum IL-6 were not different between the two exposure groups, CRP still showed elevation in DETs compared with the control population, suggesting CRP as a more suitable serum biomarker for assessing DE exposure-induced systemic inflammation in areas with high background air PM2.5 pollution. Although both cigarette smoke and DE contribute to the extensive amount of PM2.5, organic and inorganic components attached to the particulate matter are different. Consequently, their contributions to urinary metabolites and associated health effects should be diverse. Urinary OHPh was found to be an internal biomarker exclusive for DE exposure. A similar observation was also made in coke oven workers that OHPh was associated with exposure categories of coke-oven emissions but not with cigarette smoke (Serdar et al., 2003) . Using PCA, PC2, which explained 18% of total variance of the four types of urinary metabolites, was generated as an exposure index exclusively for intensity of cigarette smoking, whereas the PC1, which explained 76% of the total variance, predominantly reflected DE exposure. With these exposure indexes that precisely estimated the exposure to DE or cigarette smoke, we identified serum CC16 and CRP levels as being associated with DE exposure in a dose-dependent manner, and FeNO was associated with cigarette smoking in a dose-dependent manner as well. Furthermore, as a starting point for regulatory efforts to help decrease the risk of lung injury for male DET workers, we estimated a range of BMDLs of 1.0261-1.4513 lg OHPh/g creatinine in urine in this occupational population based on the most sensitive serum biomarker for lung injury (ie, CC16). Although the exact PM2.5 components from different exposure sources responsible for these lung health-related biomarker alterations remain elusive, our study sheds light on the methodology and concept that could assist in identifying specific component(s) as targets for development of clean air technologies and fuels (Adar et al., 2015; Eastwood, 2008; Hennig et al., 2014; Steiner et al., 2016) .
The major limitation of this study is that there should be no photo-and atmospheric chemistry occurred inside the workshop. Second, the cross-sectional design of this study does not allow for assessing the effect of local and systemic inflammatory markers measured at baseline and their change over time on subsequent FEV1 decline, a hypothesis for testing upon the availability of longitudinal data. Third, additional acute phase reactants such as serum amyloid P and serum amyloid A may also contribute to DE exposure-induced lung impairment, a hypothesis for future testing.
The major strengths of this study include the utility of a unique and well-defined DET cohort with DE exposure as the major ambient pollution source inside the workshop. Second, multiple internal exposure biomarkers were measured in urine and provide a precise estimate of exposure levels from DE or cigarette smoke.
In conclusion, our study identified strong epidemiological evidence that local (ie, CC16) and systemic (ie, CRP) inflammation may be key processes that contribute to the subsequent development of obstructive lung disease in DE-exposed populations. Future intervention with medications targeting circulating CRP (Nemmar et al., 2015 (Nemmar et al., , 2012 Oh et al., 2011; Walther et al., 2014) and supplementation of CC16 in the lung through an aerosol delivery technique (Walther et al., 2014) may reduce systemic and local inflammation and slow down FEV1 decline in young DETs. Moreover, because overweight is associated with greater local and systemic inflammation, DETs who are overweight may benefit most from such intervention. Finally, a range of BMDLs for urinary OHPh is also recommended for regulatory risk assessment in this occupational population to protect from chronic lung injury.
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